http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007124372-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c38c7c5ba7d06ba5187ddf5f2df1dbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15b4a86ca6d7b40a01472e10f7b376f2
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0009
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00
filingDate 2007-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8c23193edd22517dda44db6edb14e43
publicationDate 2008-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007124372-A3
titleOfInvention Pharmaceutical formulations for iontophoretic methotrexate delivery
abstract Pharmaceutical formulations suitable for iontophoresis that provide enhanced iontophoretic delivery of methotrexate to at least one target tissue are described and methods for administering methotrexate via iontophoresis.
priorityDate 2006-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003149393-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005153969-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5674521-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005004509-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5441732-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003086972-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4112

Total number of triples: 25.